Two Sigma Investments
ABMD

Two Sigma Investments’s Abiomed Inc ABMD Stock Holding History

Two Sigma Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,438
Closed -$3.06M – 3198
2022
Q3 		$3.06M Sell
12,438
-23,149
-65% -$6.25M 0.01% 969
2022
Q2 		$8.81M Buy
35,587
+24,934
+234% +$6.73M 0.03% 558
2022
Q1 		$3.53M Sell
10,653
-70,557
-87% -$21.7M 0.01% 1094
2021
Q4 		$29.2M Buy
81,210
+12,878
+19% +$4.35M 0.06% 357
2021
Q3 		$22.2M Sell
68,332
-22,092
-24% -$7.48M 0.05% 434
2021
Q2 		$28.2M Buy
90,424
+12,738
+16% +$3.91M 0.06% 372
2021
Q1 		$24.8M Buy
77,686
+62,580
+414% +$20M 0.06% 358
2020
Q4 		$4.9M Sell
15,106
-105,122
-87% -$29.1M 0.01% 946
2020
Q3 		$33.3M Buy
120,228
+100,896
+522% +$29.1M 0.12% 181
2020
Q2 		$4.67M Buy
19,332
+14,090
+269% +$2.83M 0.02% 668
2020
Q1 		$761K Sell
5,242
-121,731
-96% -$20.2M 0.01% 1630
2019
Q4 		$21.7M Buy
+126,973
New +$23.5M 0.07% 353
2019
Q3 		– Sell
-170,818
Closed -$36.9M – 3900
2019
Q2 		$44.5M Buy
170,818
+169,745
+15,820% +$45M 0.15% 164
2019
Q1 		$306K Sell
1,073
-11,817
-92% -$3.93M ﹤0.01% 2586
2018
Q4 		$4.19M Buy
12,890
+5,632
+78% +$1.96M 0.02% 886
2018
Q3 		$3.26M Sell
7,258
-406,151
-98% -$160M 0.01% 1152
2018
Q2 		$169M Buy
413,409
+380,507
+1,156% +$138M 0.5% 11
2018
Q1 		$9.57M Buy
32,902
+15,229
+86% +$3.86M 0.03% 612
2017
Q4 		$3.31M Sell
17,673
-59,937
-77% -$11.2M 0.01% 1136
2017
Q3 		$13.1M Sell
77,610
-51,734
-40% -$7.82M 0.05% 433
2017
Q2 		$18.5M Buy
129,344
+110,931
+602% +$14.9M 0.07% 346
2017
Q1 		$2.31M Buy
18,413
+7,013
+62% +$813K 0.01% 1371
2016
Q4 		$1.28M Sell
11,400
-159,346
-93% -$18.5M ﹤0.01% 1836
2016
Q3 		$22M Buy
170,746
+35,631
+26% +$4.27M 0.08% 278
2016
Q2 		$14.8M Buy
135,115
+46,023
+52% +$4.58M 0.06% 365
2016
Q1 		$8.45M Buy
89,092
+75,698
+565% +$6.39M 0.04% 499
2015
Q4 		$1.21M Sell
13,394
-246,555
-95% -$20.9M 0.01% 1375
2015
Q3 		$24.1M Buy
259,949
+26,340
+11% +$2.32M 0.12% 199
2015
Q2 		$15.4M Buy
233,609
+114,683
+96% +$7.62M 0.07% 324
2015
Q1 		$8.51M Sell
118,926
-16,132
-12% -$876K 0.04% 522
2014
Q4 		$5.14M Buy
+135,058
New +$4.26M 0.03% 634
2013
Q4 		– Sell
-13,746
Closed -$262K – 2440
2013
Q3 		$262K Sell
13,746
-115,706
-89% -$2.65M ﹤0.01% 1548
2013
Q2 		$2.79M Buy
+129,452
New +$2.6M 0.02% 734

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Investments's ABMD Position: Q4 2022 in Review

Two Sigma Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,438 shares — an estimated $3.06M sold.

Two Sigma Investments first reported a position in ABMD in Q2 2013 and held it in 33 quarters. The position peaked at $169M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Two Sigma Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 12,438 Abiomed Inc shares in Q4 2022, an estimated $3.06M.
  • Two Sigma Investments first reported a position in Abiomed Inc in Q2 2013 and held it in 33 quarters.
  • Two Sigma Investments's Abiomed Inc position peaked at $169M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.